Tag: Sanofi multiple sclerosis medication development
Sanofi’s New Multiple Sclerosis Pill Succeeds in Key Trial: Boosting Research Ambitions
Sanofi recently announced a major breakthrough in the treatment of multiple sclerosis with the success of their new oral pill, tolebrutinib, in a key phase 3 trial. This development has significant implications for the...